Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Awan
Farrukh
F
Hamadani
Mehdi
M
Devine
Steven
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis; D005047:Etoposide / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007249:Inflammation / Q000175:diagnosis; D007948:Leukemia, Monocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use; D009503:Neutropenia / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D016463:Sweet Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone